Results 151 to 160 of about 5,946 (190)

Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs. [PDF]

open access: yesJ Vet Pharmacol Ther
Nederveld SM, Krautmann MJ, Mitchell J.
europepmc   +1 more source

Re-emergence of COVID-19 and preparedness.

open access: yesIndian J Pharmacol
Choudhary G, Rajput H, Medhi B.
europepmc   +1 more source

Methodological and regulatory considerations for causal AI in drug development. [PDF]

open access: yesNPJ Digit Med
Lee H   +6 more
europepmc   +1 more source

A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases. [PDF]

open access: yesACR Open Rheumatol
Caricchio R   +11 more
europepmc   +1 more source

Systematic Review of Active Safety Surveillance of Vaccines and Medicines in Low- and Middle-Income Countries. [PDF]

open access: yesDrug Saf
Stergachis A   +7 more
europepmc   +1 more source

Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. [PDF]

open access: yesGut
Tseng CH   +16 more
europepmc   +1 more source

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.

open access: yesVaccine
Ibarz-Pavon AB   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy